Kil Whoon Jong, Smith Wyatt, Herndon Craig, Shipe Warren
Radiation Oncology, UPMC Hillman Cancer Center, Williamsport, Pennsylvania.
Department of Radiation Oncology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Adv Radiat Oncol. 2024 Feb 15;9(6):101472. doi: 10.1016/j.adro.2024.101472. eCollection 2024 Jun.
To report continuous positive airway pressure (CPAP)-assisted breathing with supine tangential left breast radiation therapy (CPAP-RT) when deep inspiration breath-hold RT (DIBH-RT) was ineffective or unsuitable.
Ten patients with left breast cancer underwent computed tomography simulation scan (CT-sim) under DIBH followed by CPAP-assisted breathing (15 cm HO) to create CPAP-RT plans in authors' institute. Reasons for CPAP-RT include inability to reproduce DIBH (n = 5), DIBH-RT plan exceeded dose limits to the heart (n = 2), and unable to proceed with planned DIBH-RT due to mechanical issues (n = 3). Radiation target volumes and organs at risk were contoured according to published atlas data. For dosimetric comparison, supine tangential fields for breast only RT (Breast-RT) and wide-tangential fields for breast + internal mammary nodal RT (Breast + IMN-RT) were used with prescription of 40 Gy in 15 fractions on each patients' CT-sim with free-breathing (FB), DIBH, and CPAP-assisted breathing, respectively.
Planning target volume (PTV) coverage was acceptable and comparable in all RT plans. Compared with FB, both DIBH and CPAP-assisted breathing inflated the thorax and increased left lung volume on average by 46% and 51%, respectively (FB: 1230 vs DIBH: 1802 vs CPAP-assisted breathing:1860 cc, < .01), and increased the shortest distance between PTVeval-Breast to the heart by 5.6 ± 3.0 and 11.9 ± 3.6 mm ( < .01) and to LAD by 4.9 ± 2.9 and 10.8 ± 4.3 mm, respectively ( < .01). Compared with FB, both DIBH and CPAP significantly reduced radiation dose to the heart and LAD. A mean dose to the heart (Heart) was FB: 2.3 ± 0.9, DIBH: 1.2 ± 0.7, and CPAP: 0.9 ± 0.4 Gy in Breast-RT ( < .01); FB: 3.2 ± 1.7, DIBH: 1.7 ± 0.8, and CPAP: 1.3 ± 0.5 Gy in Breast + IMN-RT ( < .01). LAD was FB: 11 ± 4.5, DIBH: 5.4 ± 3.2, and CPAP: 2.4 ± 0.9 Gy in Breast-RT ( < .01); FB: 15.5 ± 7.8, DIBH: 7.4 ± 4.1, and CPAP: 3.5 ± 1.4 Gy in Breast + IMN-RT ( < .01). A maximum dose to LAD (LAD) was FB: 35.8 ± 8.7, DIBH: 22.4 ± 15.4, and CPAP: 7.8 ± 5.3 Gy in Breast-RT ( < .01); FB: 38.7 ± 5.0, DIBH: 25.3 ± 15.2, and CPAP: 10.2 ± 6.8 Gy in Breast + IMN-RT ( < .01). All patients successfully completed CPAP-RT.
CPAP-RT provides efficient and practical heart and LAD sparing RT using simple supine tangential fields for Breast-RT or wide-tangential fields for Breast + IMN-RT when DIBH-RT was ineffective or unsuitable. With its easy accessibility and low infrastructural requirement, CPAP-RT can provide affordable heart-sparing left breast RT to reduce the health care disparities in low-resource settings.
报告在深吸气屏气放疗(DIBH-RT)无效或不适用时,采用持续气道正压通气(CPAP)辅助呼吸进行仰卧位左侧乳腺切线放疗(CPAP-RT)的情况。
10例左侧乳腺癌患者在作者所在机构接受了DIBH下的计算机断层扫描模拟扫描(CT-sim),随后采用CPAP辅助呼吸(15 cm H₂O)以制定CPAP-RT计划。采用CPAP-RT的原因包括无法重现DIBH(n = 5)、DIBH-RT计划超出心脏剂量限制(n = 2)以及因机械问题无法进行计划的DIBH-RT(n = 3)。根据已发表的图谱数据勾勒放射治疗靶区体积和危及器官。为进行剂量学比较,分别在每位患者的CT-sim上,使用仅用于乳腺放疗的仰卧位切线野(Breast-RT)和用于乳腺+内乳淋巴结放疗的宽切线野(Breast + IMN-RT),在自由呼吸(FB)、DIBH和CPAP辅助呼吸状态下,处方剂量为40 Gy,分15次照射。
所有放疗计划的计划靶区(PTV)覆盖情况均可接受且具有可比性。与FB相比,DIBH和CPAP辅助呼吸均使胸廓扩张,左肺体积平均分别增加46%和51%(FB:1230 vs DIBH:1802 vs CPAP辅助呼吸:1860 cc,P <.01),并使PTVeval-Breast到心脏的最短距离分别增加5.6±3.0和11.9±3.6 mm(P <.01),到左前降支(LAD)的最短距离分别增加4.9±2.9和10.8±4.3 mm(P <.01)。与FB相比,DIBH和CPAP均显著降低了心脏和LAD的放射剂量。在Breast-RT中,心脏的平均剂量为FB:2.3±0.9,DIBH:1.2±0.7,CPAP:0.9±0.4 Gy(P <.01);在Breast + IMN-RT中,FB:3.2±1.7,DIBH:1.7±0.8,CPAP:1.3±0.5 Gy(P <.01)。在Breast-RT中,LAD的剂量为FB:11±4.5,DIBH:5.4±3.2,CPAP:2.4±0.9 Gy(P <.01);在Breast + IMN-RT中,FB:15.5±7.8,DIBH:7.4±4.1,CPAP:3.5±1.4 Gy(P <.01)。LAD的最大剂量在Breast-RT中为FB:35.8±8.7,DIBH:22.4±15.4,CPAP:7.8±5.3 Gy(P <.01);在Breast + IMN-RT中为FB:38.7±5.0,DIBH:25.3±15.2,CPAP:10.2±6.8 Gy(P <.01)。所有患者均成功完成CPAP-RT。
当DIBH-RT无效或不适用时,CPAP-RT使用简单的仰卧位切线野进行Breast-RT或宽切线野进行Breast + IMN-RT,可有效且切实地实现对心脏和LAD的放疗保护。因其易于实施且对基础设施要求低,CPAP-RT可为资源匮乏地区提供经济实惠的心脏保护左侧乳腺放疗,以减少医疗保健差距。